top of page

WHAT IS ISBT 128?

WHO USES ISBT 128?

COUNTRIES WITH ACTIVE REGISTERED FACILITIES
Andorra
Dominican Republic
Kenya
Romania
Argentina
Ecuador
Kuwait
San Marino
Aruba
Egypt, Arab Rep.
Latvia
Saudi Arabia
Australia
Estonia
Lebanon
Singapore
Austria
Finland
Lithuania
Slovakia
Bahrain
France
Malaysia
Slovenia
Belgium
Germany
Malta
South Africa
Brazil
Greece
Mexico
Spain
Canada
Honduras
Mozambique
Sweden
Cayman Islands
Hungary
Netherlands
Switzerland
Chile
Iceland
New Zealand
Taiwan, China
China
India
Norway
Thailand
Colombia
Indonesia
Oman
Türkiye
Costa Rica
Iran, Islamic Rep.
Pakistan
Ukraine
Croatia
Ireland
Panama
United Arab Emirates
Curacao
Israel
Philippines
United Kingdom
Cyprus
Italy
Poland
United States
Czech Republic
Japan
Portugal
Vietnam
Denmark
Jordan
Qatar

 If your country is not listed, please notify us.

Who uses ISBT
User Experience

ISBT 128 USER EXPERIENCE

SOFTWARE DEVELOPER

"In addition to being beneficial for donors, patients, and safety, ISBT 128 has been very beneficial for the vendors of IT systems. It enables several IT systems to coexist in a country or a region, since all exchanged blood products are uniformly labeled and carry all relevant information. ISBT 128 reduces vendors' cost since we can focus on one standard when implementing the business logic for products and bedside control. We anticipate future standards for interfacing production equipment."

RENNY SKAGSTAD
CEO  
LabCraft AS 
Oslo, Norway 
bottom of page